Please confirm you are human (Sign Up for free to never see this)
← Back to Search
Automated Volumetric Radiomic Analysis Of Breast Cancer Vascularization Improves Survival Prediction In Primary Breast Cancer
M. Dietzel, R. Schulz-Wendtland, Stephan Ellmann, R. Zoubi, E. Wenkel, M. Hammon, P. Clauser, M. Uder, I. Runnebaum, P. Baltzer
Published 2020 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
To investigate whether automated volumetric radiomic analysis of breast cancer vascularization (VAV) can improve survival prediction in primary breast cancer. 314 consecutive patients with primary invasive breast cancer received standard clinical MRI before the initiation of treatment according to international recommendations. Diagnostic work-up, treatment, and follow-up was done at one tertiary care, academic breast-center (outcome: disease specific survival/DSS vs. disease specific death/DSD). The Nottingham Prognostic Index (NPI) was used as the reference method with which to predict survival of breast cancer. Based on the MRI scans, VAV was accomplished by commercially available, FDA-cleared software. DSD served as endpoint. Integration of VAV into the NPI gave NPI VAV . Prediction of DSD by NPI VAV compared to standard NPI alone was investigated (Cox regression, likelihood-test, predictive accuracy: Harrell’s C, Kaplan Meier statistics and corresponding hazard ratios/HR, confidence intervals/CI). DSD occurred in 35 and DSS in 279 patients. Prognostication of the survival outcome by NPI (Harrell’s C = 75.3%) was enhanced by VAV (NPI VAV : Harrell’s C = 81.0%). Most of all, the NPI VAV identified patients with unfavourable outcome more reliably than NPI alone (hazard ratio/HR = 4.5; confidence interval/CI = 2.14-9.58; P = 0.0001). Automated volumetric radiomic analysis of breast cancer vascularization improved survival prediction in primary breast cancer. Most of all, it optimized the identification of patients at higher risk of an unfavorable outcome. Future studies should integrate MRI as a “gate keeper” in the management of breast cancer patients. Such a “gate keeper” could assist in selecting patients benefitting from more advanced diagnostic procedures (genetic profiling etc.) in order to decide whether are a more aggressive therapy (chemotherapy) is warranted.
This paper references
Chemotherapy decisions and patient experience with the recurrence score assay for early‐stage breast cancer
C. Friese (2017)
An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers
A. F. Vieira (2018)
MRI of the female breast. First clinical results.
W. Kaiser (1985)
who underwent a 21 - gene expression assay : Outcomes With 21 - Gene Expression
C. Verschraegen (2017)
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data
E. Oikonomou (2018)
Pretreatment Prognostic Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Vascular, Texture, Shape, and Size Parameters Compared With Traditional Survival Indicators Obtained From Locally Advanced Breast Cancer Patients
M. Pickles (2016)
Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
J. Kim (2017)
Perfusion and vascular permeability : Basic concepts and measurement in DCE-CT and DCE-MRI
C. A. Cuenoda (2013)
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
A. Atkinson (2001)
Breast MRI: guidelines from the European Society of Breast Imaging
R. Mann (2008)
Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging
Ziliang Cheng (2017)
TNM Classification of Malignant Tumours
M. Gospodarowicz (1987)
Outcomes in patients with early‐stage breast cancer who underwent a 21‐gene expression assay
C. Barcenas (2017)
A prognostic index in primary breast cancer.
J. Haybittle (1982)
Tumor Heterogeneity in Breast Cancer
S. Badve (2015)
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
C. Hudis (2007)
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
H. Li (2016)
MRI of the female breast
W. Kaiser (1985)
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M. Hammond (2010)
Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999.
R. Blamey (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.
A. Wolff (2007)
Disease‐specific death and metastasis do not occur in patients with Gleason score ≤6 at radical prostatectomy
Charlotte F. Kweldam (2015)
Potential of MR mammography to predict tumor grading of invasive breast cancer.
M. Dietzel (2011)
Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL.
N. Hylton (2012)
Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.
H. Dvorak (2002)
The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer
V. Sopik (2018)
Population‐based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years
A. Potosky (2015)
Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.
L. Buadu (1996)
Tumours of the Breast
A. Templeton (1894)
Interdisziplinäre S3-Leitlinie für die Diagnostik, Therapie und Nachsorge des Mammakarzinoms
R. Kreienberg (2013)
Tumours of the breast. in World Health Organization Classifica- tion of Tumours. Pathology and Genetics.Tumours of the Breast and Female Genital Organs 9–112
A. Fattaneh (2003)
Invasive lobular carcinoma of the breast: morphology, biomarkers and ’omics
A. E. M. Reed (2015)
Index for rating diagnostic tests
W. Youden (1950)
What is the evidence that tumors are angiogenesis dependent?
J. Folkman (1990)
SEER Stat Fact Sheets : Female Breast Cancer
A. W. Kurian
Role of angiogenesis in tumor growth and metastasis.
J. Folkman (2002)
The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language?
D. Vanel (2007)
ACR BI-RADS ® Magnetic Resonance Imaging
E A Morris (2013)
World Health Organization Classification of Tumours
C. Fletcher (2002)
Effects of MRI scanner parameters on breast cancer radiomics
Ashirbani Saha (2017)
Confirmation of a prognostic index in primary breast cancer.
J. Todd (1987)
20‐Year Risks of Breast‐Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan (2017)
Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
S. Li (2011)
Diagnostik, Therapie und Nachsorge des Mammakarzi- noms der Frau S3 Leitlinie
R. Kreienberg (2004)
Modeling the Effect of Tumor Size in Early Breast Cancer
C. Verschraegen (2005)
Precision Medicine in Breast Cancer Care An Early Glimpse of Impact
Swain Sm (2016)
Population-based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 years: Breast Cancer Genetics and Chemotherapy
DKG), und Deutsche Gesellschaft für Gynäkologie und & Geburtshilfe (DGGG)
E DeutscheVKrebsgesellschaft (2008)
Dynamic MR imaging of the breast: Analysis of kinetic and morphologic diagnostic criteria
B. Szabó (2003)
Computer Assisted Analysis of MR-Mammography Reveals Association between Contrast Enhancement and Occurrence of Distant Metastasis
P. Baltzer (2012)
The Necrosis Sign in Magnetic Resonance‐Mammography: Diagnostic Accuracy in 1,084 Histologically Verified Breast Lesions
M. Dietzel (2010)
How to use the Kaiser score as a clinical decision rule for diagnosis in multiparametric breast MRI: a pictorial essay
M. Dietzel (2018)
Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.
B. Uzzan (2004)
MRI kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers.
L. Leong (2015)
The 2019 World Health Organization classification of tumours of the breast
P. Tan (2020)
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.
N. Hylton (2016)
Radiomics: Images Are More than Pictures, They Are Data
R. Gillies (2016)
Color-Coded Automated Signal Intensity Curves for Detection and Characterization of Breast Lesions: Preliminary Evaluation of a New Software Package for Integrated Magnetic Resonance-Based Breast Imaging
F. Pediconi (2005)
The Nottingham Prognostic Index: five- and ten-year data for all-cause survival within a screened population.
Y. Fong (2015)
Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group.
P. Boiesen (2000)
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up.
C. Elston (2002)
Predicting survival and early clinical response to primary chemotherapy for patients with locally advanced breast cancer using DCE‐MRI
Roar Johansen (2009)
ACR BI-RADS® Magnetic Resonance Imaging. in ACR BI-RADS® Atlas, Breast Imaging Reporting and Data System (American
Computer Assisted Analysis of MR-Mammography Reveals Association Between Contrast Enhancement and Occurrence of Distant Metastasis. Technology in cancer
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
E. R. Delong (1988)
Tumours of the breast. in World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs 9–112
A. Fattaneh (2003)
Interobserver Variability Between Breast Imagers Using the Fifth Edition of the BI-RADS MRI Lexicon.
L. Grimm (2015)
A time-dependent discrimination index for survival data.
L. Antolini (2005)
Association between survival in patients with primary invasive breast cancer and computer aided MRI
M. Dietzel (2013)
This paper is referenced by
A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer
Aydin Demircioglu (2020)